Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential – A Comparison of Two Cases
Pseudomyxoma peritonei (PMP) is a rare tumor syndrome that can be diagnosed in association with mucinous ovarian tumors of low malignant potential. Surgical debulking is the primary treatment modality as chemotherapy has generally proven ineffective in this slowly progressive tumor. When patients wi...
Main Authors: | Ira Winer, Ronald J. Buckanovich |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2009-01-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/270179 |
Similar Items
-
Characterization of Pseudomyxoma Peritonei Originating from Ovarian Borderline Mucinous Tumor Using Ultrasonography: A Case Report
by: Shi Qiao, MM, Shaote Wang, MD, Yao Deng, MD, Feixiang Xiang, MD, Xiaojuan Qin, MD
Published: (2023-03-01) -
Under the Hood: Understanding the Features of Mucin in Pseudomyxoma Peritonei
by: Pedro Villarejo-Campos, et al.
Published: (2023-06-01) -
Pseudomyxoma peritonei of appendiceal origin mimicking ovarian cancer –
a case report with literature review
by: Stoyan Kostov, et al.
Published: (2021-09-01) -
Novel Perspectives in Pseudomyxoma Peritonei Treatment
by: Antonio Sommariva, et al.
Published: (2021-11-01) -
Diagnostic and Therapeutic Algorithm for Appendiceal Tumors and Pseudomyxoma Peritonei: A Consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO)
by: Marco Vaira, et al.
Published: (2023-01-01)